Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-07

Clinical Trial Update: Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment

View source ↗

Summary

A completed clinical trial update assessing quality of life in Korean postmenopausal osteoporosis patients treated with bisphosphonates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bisphosphonates (bisphosphonate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis, Postmenopausal | Status: COMPLETED